Adiponectin Influences the Behavior of Stem Cells in Hormone-Resistant Breast Cancer
Cells · 2025
DOI: 10.3390/cells14040286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Giuseppina Daniela Naimo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, CS, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Adiponectin, Neoplastic Stem Cells, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, PON Salute SI.F.I.PA.CRO.DE., MIUR Excellence Department Project funds.
Abstract (Originalsprache)
In the breast tumor microenvironment (TME), adipocytes exert a selective pressure on the behavior of breast cancer stem cells (BCSCs), which are involved in endocrine therapy resistance. In obesity, adipocytes secrete reduced levels of adiponectin, which promotes the growth and progression of ERα-positive breast cancer (BC). Here, we examined how low adiponectin levels affect the enrichment of the BCSC subpopulation and the mechanisms contributing to the maintenance of endocrine therapy resistance in BC. Flow cytometry, qRT-PCR, and Western blotting analysis were performed to assess stemness, the cell cycle, and apoptosis markers in MCF-7 wild-type (WT) and tamoxifen-resistant (TR) mammospheres. nLC-MS/MS was employed to profile and compare the proteome of BCSCs. Differentially expressed proteins were intersected with data from the MetacoreTM dataset. Our study demonstrated that adiponectin increased the percentage of CD44+/CD24−/ALDH1+ stem-like cells in TR MCF-7 mammospheres. Specifically, adiponectin contributed to the maintenance of BCSC bulk in TR MCF-7 cells through a slow cycling rate, supported by decreased levels of Cyclin D1 and Ki67 and increased p21 and p27 expression, and through escape from apoptosis, sustained by reduced ROS production and preserved maintenance of mitochondrial membrane potential. Our results provide new insights into the contribution of adiponectin to poor ERα-positive BC outcomes. Deeply understanding adiponectin’s role in stemness may disclose novel therapeutic approaches to treat hormone-resistant obese BC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, CS, Italy.
- Centro Sanitario, University of Calabria, 87036 Arcavacata di Rende, CS, Italy.
ORCID-Profile: Francesca Giordano, Adele Elisabetta Leonetti, Loredana Mauro
Förderung
- Italian Association for Cancer Research
- PON Salute SI.F.I.PA.CRO.DE.
- MIUR Excellence Department Project funds
- University of Calabria
- Associazione Italiana Ricerca sul Cancro (AIRC)
- PON Salute
- Italian Minister of University and Research
Zitieren
APA
Naimo, G. D., Forestiero, M., Giordano, F., Leonetti, A. E., Gelsomino, L., Panno, M. L., Andò, S., & Mauro, L. (2025). Adiponectin Influences the Behavior of Stem Cells in Hormone-Resistant Breast Cancer. Cells. https://doi.org/10.3390/cells14040286
Vancouver
Naimo GD, Forestiero M, Giordano F, Leonetti AE, Gelsomino L, Panno ML, et al. Adiponectin Influences the Behavior of Stem Cells in Hormone-Resistant Breast Cancer. Cells. 2025. doi:10.3390/cells14040286
BibTeX
@article{Naimo2025,
author = {Naimo, Giuseppina Daniela and Forestiero, Martina and Giordano, Francesca and Leonetti, Adele Elisabetta and Gelsomino, Luca and Panno, Maria Luisa and Andò, Sebastiano and Mauro, Loredana},
title = {Adiponectin Influences the Behavior of Stem Cells in Hormone-Resistant Breast Cancer},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14040286}
}
EUVIMED